Tracking superbugs from mother to baby: a chicago study
NCT ID NCT06148480
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study looks at how drug-resistant bacteria, specifically ESBL-producing E. coli, are passed from mothers to their newborns during vaginal birth or scheduled C-sections. Researchers will test stool samples from 200 healthy mothers and their babies at a Chicago hospital to see how common these bacteria are and how often they are transmitted. By comparing the bacteria's genes, they hope to find what makes some strains better at spreading, which could lead to future ways to prevent infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify genetic targets to reduce the spread of drug-resistant bacteria from mother to baby.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead directly to new therapies, and findings may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for E. COLI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prentice Women's Hospital
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.